期刊文献+

脑胶质瘤患者围手术期外周血树突状细胞亚群变化及意义 被引量:1

下载PDF
导出
摘要 目的应用流式细胞分析技术对脑胶质瘤患者围手术期外周血树突状细胞(DC)亚群变化进行分析,探讨其数量、变化规律及不同恶性程度胶质瘤患者免疫功能的差异。方法检测试验组及对照组DC1、DC2,抽取外周血,应用流式细胞仪检测外周血DC1、DC2。结果外周血流式细胞仪结果分析,两组DC1/PBMC(外周血单个核细胞)、DC2/PBMC比较,差异有统计学意义(P<0.05)。胶质瘤患者术后早期外周血DC1/PBMC、DC2/PBMC百分比与术前比较有所下降,差异有统计学意义(P<0.05)。脑胶质瘤患者术后晚期外周血DC1/PBMC的百分比高于术后早期,差异有统计学意义(P<0.05)。恶性程度高的胶质瘤患者围手术期DC1/PBMC、DC2/PBMC低于恶性程度低的胶质瘤患者。结论脑胶质瘤患者与健康人比较,外周血中DC1/PBMC、DC2/PBMC比例下降,表明脑胶质瘤患者较健康人免疫功能降低;胶质瘤患者外周血DC亚群数量与胶质瘤恶性程度呈负相关。
出处 《检验医学与临床》 CAS 2015年第8期1112-1113,共2页 Laboratory Medicine and Clinic
基金 贵州省科学技术基金资助项目[黔科合J字(2008)2201号]
  • 相关文献

参考文献9

  • 1Reid SD, Penna G,八dorini L. The conlrol of T Cell re-sponses by dendrilie cell subsets [J]. Current Opinion inImmunol,2000,12(1); 114-121.
  • 2傅德良,倪泉兴,虞先浚,徐近,华宇明,陈炜,龙江,张群华,张延龄.围手术期胰腺癌患者细胞免疫功能的表达[J].中国临床医学,2001,8(4):339-340. 被引量:9
  • 3邢雪,吴在德,陈孝平,沈关心.肝癌患者免疫功能的临床研究[J].中华实验外科杂志,1996,13(6):333-334. 被引量:23
  • 4胡智勇,陈庆廉,胡劲,杨骅,邵传森.手术对淋巴细胞亚群细胞周期的影响[J].浙江大学学报(医学版),2000,29(1):36-37. 被引量:5
  • 5(乂 Mahony JB, Palder SB, Wood JJ? et al. Depression ofcell ularimmunity after multiple trau main the absence ofsepsis[J]. J Trauma, 1984?24( 10) :869-874.
  • 6Held FJ, Lutjohann B? Ungefroren H,et al. Interaction oftransforming growth factor-beta (TGF-bcta) and epider-mal growth factor ( EOF) in human glioma cells [J]. JNeuro-oncol, 2003,63(2) : 117-127.
  • 7Yang T,Witham TF, Villa L,et al. Glioma-associated hy-aluronan induces apoptosis in dendritic cells via induciblenitric oxide synthase : implications for the ues of dendriticcells for therapy of gliomas[J]. Cancer Res,2002,62 (9):2583-2591.
  • 8Newton PJ , Weller IV, Williams IG? et al. Monocyte de-rived dendritic cells from HIV-1 infected individuals par-tially reconstitute CD4 T-cell responses [J]. AIDS,2006,20(2):171-180.
  • 9李艳佳,齐凤英.在防治HPV感染中树突状细胞的应用研究[J].国外医学(皮肤性病学分册),2004,30(3):197-199. 被引量:3

二级参考文献31

  • 1胡智勇,朱圣禾.麻醉手术与自然杀伤细胞[J].国外医学(麻醉学与复苏分册),1993,14(6):336-337. 被引量:3
  • 2邢雪,吴在德,陈孝平,沈关心.肝癌患者免疫功能的临床研究[J].中华实验外科杂志,1996,13(6):333-334. 被引量:23
  • 3Fausch SC, Da Silva DM, Rudolf MP, et al. Human papillomavirus virus-like particles do not activate Langerhans cells: a possible immune escape mechanism used by human papillomaviruses. J Immunol,2002,169:3242 - 3249.
  • 4Doan T, Chambers M, Street M,et al. Mice expressing the E7 oncogene of HPV16 in epithelium show central tolerance, and evidence of peripheral anergising tolerance, to E7-encoded cytotoxic T-lymphocyte epitopes. Virology, 1998, 244:352 - 364.
  • 5Tuting T, DeLco AB, Lotze MT, et al. Genetically modified bone marrow-derived dendritic cells expressing lumor-associated viral or""self"" antigens induce antitumor immunity in vivo. Eur J Immunol,1997,27:2702 - 2707.
  • 6Tillman BW, Hayes TL, DeGruijl TD,et al. Adenoviral vectors targeted to CD40 enhance the efficacy of dendritic cell-based vaccination against hunan papillomavirus 16 - induced tumor cells in a murine model. Cancer Res, 2000,60:5456 - 5463.
  • 7Inaba K, Inaba M, Naito M,et al. Dendritic cell progenitors phagocyrose particulates, inluding bacillus Calmette-Guerin organisms, and sensitize mice to mycobacterial antigens in vivo. J Exp Med, 1993,178:479 -488.
  • 8Indrova M, Bubenik J, Simova J,et al. Therapy of HPV 16 - associated carcinoma with dendritic cell-based vaccines: in vitro prining of the effector cell responses by DC pulsed with tumour lysates and synthetic RAHYNIVTF peptide. Int J Mol Med, 2001,7:97 -
  • 9De Bruijn ML, Schuurhuis DH, Vierboom MP, et al. Inmunization with human papillomavirus type 16 (HPV16) oncoprotein-loaded dendritic cells as well as protein in adjuvant induces MHC class I-restricted protection to HPV16 - induced tumor cells. Cancer Res,
  • 10Sallusto F, Cella M, Danieli C, et al. Dendritic cells use macropinocytosis and the mannose receptor to concentrate macromolecules in the major histocompatibility complex class II compartment: downregulation by cytokines and bacterial products. J Exp Med,

共引文献31

同被引文献9

引证文献1

二级引证文献15

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部